Climate Change Data

Immedica Pharma Holding AB

Climate Impact & Sustainability Data (2022)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:3601.25 tCO2e/year (Scope 1: 36.65 tCO2e, Scope 2: 0.30 tCO2e, Scope 3: 3601.25 tCO2e)
Scope 1 Emissions:36.65 tCO2e/year
Scope 2 Emissions:0.30 tCO2e/year
Scope 3 Emissions:3601.25 tCO2e/year
Renewable Energy Share:100% at new HQ

ESG Focus Areas

  • Commitment to make a difference to patients’ lives
  • Sustainable organization and operations

Environmental Achievements

  • New HQ office in Stockholm sources 100% renewable energy
  • Increased share of environmentally friendly cars in the fleet from 42% to 65%

Social Achievements

  • Ravicti approved in one additional market and reimbursed in three additional markets; 160 new patients started treatment with Ravicti
  • MAA submitted to EMA for pegzilarginase for arginase 1 deficiency
  • Expanded Hematology and Oncology portfolio with Iomab-B, Aloxi, and Akynzeo
  • 100% of partners would recommend Immedica as a partner

Governance Achievements

  • Adopted several ESG-related policies (Policy for policies, IS/IT policy, Manual for crisis management, Information handling policy, GDPR policy, Communication policy, Trade sanctions policy, Social media policy)
  • Established whistle-blower hotline (SpeakUp) with zero reports in 2022
  • 99.9% of eligible employees completed Code of Conduct training

Climate Goals & Targets

Medium-term Goals:
  • By January 2024, all new cars shall be 100% hybrid or electrical
Short-term Goals:
  • Set targets for scope 1 and 2 emissions

Environmental Challenges

  • High exposure to a specific industry (pharmaceuticals) and dependence on a few major products
  • Acquired products may fail to obtain regulatory authorization
  • Competitive market with risks from new innovative products and patent expirations
  • Exposure to currency, interest rate, and liquidity risks
  • Lack of data from third-party suppliers for accurate Scope 3 emissions tracking
Mitigation Strategies
  • Ongoing liquidity planning
  • Risk mapping and monitoring
  • Working with third-party vendors to improve data quality for Scope 3 emissions

Supply Chain Management

Responsible Procurement
  • Implementing a framework for vetting potential business partners and ensuring minimum standards

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (SDGs)

UN Sustainable Development Goals

  • 3
  • 8
  • 12
  • 13
  • 16
  • 17

Initiatives contribute to these goals through patient care, employee well-being, sustainable operations, and responsible partnerships.